P A Marks
Impact in
- Molecular Biology top 0.5%
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Retinoids in leukemia and cellular processes
- RNA and protein synthesis mechanisms
- Genetics top 1%
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 17
- Acute Myeloid Leukemia Research 12
- Erythropoietin and Anemia Treatment 3
- Genetics 13
- Hemoglobinopathies and Related Disorders 13
- Co-authors
- Richard A. Rifkind (35 shared papers)Victoria M. Richon (9 shared papers)Weisheng Xu (1 shared paper)Raphael B. Parmigiani (1 shared paper)Lang Ngo (6 shared papers)Weili Xu (2 shared papers)A Bank (11 shared papers)C. Gui (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (21 papers)Journal of Biological Chemistry (6 papers)Journal of Clinical Investigation (3 papers)Oncogene (2 papers)Annual Review of Biochemistry (1 paper)
- Partner nations
- United StatesItalySweden
In The Last Decade
P A Marks
57 papers receiving 8.4k citations
P A Marks's Hit Papers
Peers
Comparison fields: 5 of 107
- Molecular Biology 6.1k
- Genetics 648
- Hematology 887
- Oncology 653
- Cancer Research 305
Countries citing papers authored by P A Marks
This map shows the geographic impact of P A Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Marks more than expected).
Fields of papers citing papers by P A Marks
This network shows the impact of papers produced by P A Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Marks. The network helps show where P A Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside P A Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Histone deacetylase inhibitors: molecular mechanisms of action Hit paper breakdown → | 2007 | 1310 |
| 2 | Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells Hit paper breakdown → | 2000 | 1035 |
| 3 | Erythroleukemic Differentiation Hit paper breakdown → | 1978 | 632 |
| 4 | Histone deacetylase inhibitors: Potential in cancer therapy Hit paper breakdown → | 2009 | 625 |
| 5 | Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. | 2000 | 548 |
| 6 | 2007 | 545 | |
| 7 | 2004 | 497 | |
| 8 | 2005 | 438 | |
| 9 | 1996 | 369 | |
| 10 | 2003 | 321 | |
| 11 | 1977 | 224 | |
| 12 | 1986 | 174 | |
| 13 | Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. | 1999 | 167 |
| 14 | 1972 | 157 | |
| 15 | The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. | 2001 | 140 |
| 16 | 1977 | 114 | |
| 17 | Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. | 2001 | 108 |
| 18 | 1973 | 99 | |
| 19 | 1975 | 94 | |
| 20 | 1972 | 93 |
About P A Marks
P A Marks is a scholar working on Hematology, Genetics, Molecular Biology, Cell Biology and Oncology, having authored 58 papers that have together received 9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (14 papers), Retinoids in leukemia and cellular processes (14 papers), Hemoglobinopathies and Related Disorders (13 papers), Acute Myeloid Leukemia Research (12 papers), RNA and protein synthesis mechanisms (8 papers), Genomics and Chromatin Dynamics (7 papers), Hemoglobin structure and function (4 papers) and Erythropoietin and Anemia Treatment (3 papers). The work is most often cited by research in Molecular Biology (6.1k citations), Genetics (648 citations), Hematology (887 citations), Oncology (653 citations) and Cancer Research (305 citations). P A Marks has collaborated with scholars based in United States, Italy and Sweden. Frequent co-authors include Richard A. Rifkind, Victoria M. Richon, Weisheng Xu, Raphael B. Parmigiani, Lang Ngo, Weili Xu, A Bank, C. Gui, M Terada and Lisa M. Butler. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Journal of Clinical Investigation, Oncogene and Annual Review of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.